Kazia Therapeutics KZIA
NASDAQ KZIA
$8.18 +0.30 (+3.81%)
At close: Oct 21, 2026 · 4:00 PM EDT

Kazia Therapeutics (KZIA) Operating Margin (2009)

Updated

Kazia Therapeutics' Operating Margin came in at 756.34% for the year ended Jun 30, 2011, down 180.39 percentage points from 936.73% a year earlier.

Analysis

Kazia Therapeutics (KZIA) Operating Margin (2009) Analysis & Trends

  • Per Business Quant, earlier years put Operating Margin at 936.73% in the year ended Jun 30, 2010 (+756.16 pp) and 180.56% in the year ended Jun 30, 2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 28.21%
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 37.86%
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -3.52%
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 32.97%
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 20.57%
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 34.95%
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -133.21%
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 28.37%
10 Kazia Therapeutics 606,664.05 -51.76 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2009 108.11%
API Access

Kazia Therapeutics Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=KZIA&period=max&api_key=YOUR_API_KEY